ACEing COVID-19: A Role for Angiotensin Axis Inhibition in SARS-CoV-2 Infection?
- PMID: 32302248
- PMCID: PMC7274880
- DOI: 10.1161/CIRCRESAHA.120.317174
ACEing COVID-19: A Role for Angiotensin Axis Inhibition in SARS-CoV-2 Infection?
Keywords: COVID-19; Editorials; angiotensin II; hypertension; infections.
Comment on
-
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17. Circ Res. 2020. PMID: 32302265 Free PMC article.
References
-
- https://www.goodreads.com/quotes/4117-there-are-in-fact-two-things-scien.... Accessed 16 April 2020.
-
- European Societies of Cardiology. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/pos.... Accessed 16 April 2020.
-
- HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-.... Accessed 16 April 2020. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous